SAM CHUN DANG PHARM CO. LTD Large-holding report amended: related party Jeon In-seok extends share pledge period
SAI summary · Not investment advice
The group led by Yoon Dae-in holds 37.61% of all shares, unchanged, and 896,718 shares are covered by pledge contracts.
Key facts
- Stake
- 37.61%
- Previous stake
- 37.61%
- Change in stakeCalculated by HeyHolder
- 0.00%pcurrent − previous
- Purpose of holding
- Influence on management control
- Reason for amendment
- Extension of the share pledge contract term of related party Jeon In-seok
- Previous shares held
- 8,821,895 shares
- Shares held
- 8,821,895 shares
Commentary
AI commentary · Not investment advice
What happened
Samchundang Pharm reported that related parties (people or companies counted together with the filer, such as family or the same group) extended a share pledge period for Jeon In-seok. Some of their shares are pledged as collateral. The shares covered by pledge contracts total 896,718.
In the company's terms
The pledge contracts for Jeon In-seok cover 209,300, 121,433 and 72,652 shares. Those for Yoon Eun-hwa cover 128,310 and 165,023 shares. Both also gave 100,000 shares each as tax collateral to the Yongsan Tax Office on April 1, 2026.
What changes for shareholders
The stated purpose of holding is influence over management. The ownership stake was 37.61% before and is 37.61% now. The change is 0.00%p (Hey Holder calculation). The number of shares held is 8,821,895 both before and now.
Earlier Report on Large Shareholdings filings from this company
| Filed | Reporting holder | Stake | Change |
|---|---|---|---|
| 26.10.202026.10.20 | Yoon Dae In and 4 related parties | 37.61% | 0.00%p |
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist